Foghorn Therapeutics Inc. reports results for the quarter ended in June - Earnings Summary

Foghorn Therapeutics

12/08/2021 13:40

* Foghorn Therapeutics Inc.  FHTX.OQ  reported a quarterly
adjusted loss of 63 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 63 cents per share.
* Revenue was $279.00 thousand​;  analysts expected $250.00
thousand. 
* Foghorn Therapeutics Inc.'s reported EPS for the quarter was a
loss of 63 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Foghorn Therapeutics Inc. shares had fallen by 15.8% this
quarter and lost 55.7% so far this year.
* The company reported a quarterly loss of $23.11 million.
* Wall Street's median 12-month price target for Foghorn
Therapeutics Inc. is $24.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 12:40 p.m.  ​All
figures in US dollars unless otherwise stated